These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29752299)

  • 1. ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.
    Michael Besser G; Pfeiffer RF; Thorner MO
    Eur J Endocrinol; 2018 Aug; 179(2):R69-R75. PubMed ID: 29752299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergotism and Saint Anthony's fire.
    Grzybowski A; Pawlikowska-Łagód K; Polak A
    Clin Dermatol; 2021; 39(6):1088-1094. PubMed ID: 34920829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of ergot alkaloids from ergotism to ergometrine.
    van Dongen PW; de Groot AN
    Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):109-16. PubMed ID: 7641960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The history of ergot of rye (Claviceps purpurea) III: 1940-80.
    Lee MR
    J R Coll Physicians Edinb; 2010 Mar; 40(1):77-80. PubMed ID: 20503690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The history of ergot of rye (Claviceps purpurea) I: from antiquity to 1900.
    Lee MR
    J R Coll Physicians Edinb; 2009 Jun; 39(2):179-84. PubMed ID: 19847980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The history of ergot of rye (Claviceps purpurea) II: 1900-1940.
    Lee MR
    J R Coll Physicians Edinb; 2009 Dec; 39(4):365-9. PubMed ID: 20509463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Saint Anthony's Fire or gangrenous ergotism and its medieval iconography].
    Battin J
    Hist Sci Med; 2010; 44(4):373-82. PubMed ID: 21598563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bromocriptine: uses until now and prospects of new therapeutic applications].
    Górska D
    Neurol Neurochir Pol; 2000; 34(3):573-8. PubMed ID: 10979549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine.
    Roehrich H; Dackis CA; Gold MS
    Med Res Rev; 1987; 7(2):243-69. PubMed ID: 3553782
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
    Pullan PT
    Intern Med J; 2009 Apr; 39(4):213-5. PubMed ID: 19402858
    [No Abstract]   [Full Text] [Related]  

  • 11. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
    Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
    Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convulsive ergotism: epidemics of the serotonin syndrome?
    Eadie MJ
    Lancet Neurol; 2003 Jul; 2(7):429-34. PubMed ID: 12849122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective mechanism of bromocriptine.
    Yamashita H; Kawakami H; Zhang YX; Tanaka K; Nakamura S
    Lancet; 1995 Nov; 346(8985):1305. PubMed ID: 7475755
    [No Abstract]   [Full Text] [Related]  

  • 14. Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
    Tashiro K; Goto I; Kanazawa I; Kowa H; Kuno S; Mizuno Y; Ogawa N; Yanagisawa N
    Eur Neurol; 1996; 36 Suppl 1():32-7. PubMed ID: 8791019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus.
    Weiland CM; Hilaire ML
    Am Fam Physician; 2013 May; 87(10):718-20. PubMed ID: 23939451
    [No Abstract]   [Full Text] [Related]  

  • 18. The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
    Fahn S
    Mov Disord; 2015 Jan; 30(1):4-18. PubMed ID: 25491387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
    Bonnet AM; Serre I; Marconi R; Agid Y; Dubois B
    Mov Disord; 1995 Sep; 10(5):668-71. PubMed ID: 8552122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine therapy: Review of mechanism of action, safety and tolerability.
    Naz F; Malik A; Riaz M; Mahmood Q; Mehmood MH; Rasool G; Mahmood Z; Abbas M
    Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):903-922. PubMed ID: 35635035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.